To fully participate in this online program you must be registered and logged in. Read all the information presented below. When ready select the "View Program" tab above.
Claiming CME/CE Credits
To receive CME/CE credits, participants must review the program materials in their entirety and complete the online post examination and evaluation with a score of 75% or better.
System Hardware/Software and Internet Connection Requirements
The following information is provided for your reference in conjunction with review of this program.
General System and Internet Requirements: Speakers or Headphones, High Speed Internet connection, Wireless 3G and 4G,
Web browsers: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher and Chrome.
Operating Systems: Windows 2000 or higher, (MS Surface and other MS mobile devices compatible), MAC OSX 10.3 or higher, Mac iOS 5.0 or higher (iPad, iPhone compatible), Android 4.3 or higher (most Android mobile devices compatible).
In this final segment of this 3-part series, Dr. Laurie Fajardo addresses the radiologist’s challenges associated with dense breast imaging and interpretation through discussion and case presentation of interval breast cancer. This includes issues associated with assigning breast cancer risk to breast density and qualitative versus quantitative methods for assessing, and reporting breast density and risk assessment.
Further Dr. Fajardo will discuss how to incorporate breast cancer risk assessment into your breast imaging practice and closes the program with a discussion on the current impact of Artificial Intelligence on breast imaging and how it can enhance workflow.
CME Effective Date: October 20, 2020
CME Expiration Date: October 31, 2022
CE Effective Date: October 20, 2020
CE Expiration Date: October 31, 2022
Format: Self Instructional - Audio Visual with Slides
One and a half (1.5) AMA/PRA Category 1 CME Credit™
One and a half (1.5) ARRT Category A CE Credit.
One and a half (1.5) AHRA CRA Credit
Estimated Completion Time: 1 hour 30 minutes
This program is supported through an unrestricted educational grant from FUJIFILM Medical Systems U.S.A., Inc.
This program is intended for: Radiologists, Other MD's, Radiologic Technologists, Radiology Administrators and related Imaging Professionals.
There is no cost to participate in this program.
Upon completion of this CME activity the healthcare provider should be able to:
No special educational preparation is required for this CME/CE Activity!
Laurie L. Fajardo, MD, MBA, FACR, FSBI
Department of Radiology and Imaging Sciences
University of Utah School of Medicine
Salt Lake City, Utah
Laurie Fajardo, MD, MBA, FACR, FSBI is a Professor of Radiology at the University of Utah. Her research efforts have focused on all aspects of breast imaging including new methods and applications of digital technologies, most recently DBT and phase contrast breast imaging. Her contributions to science include the development and clinical evaluation of Stereotactic Breast Biopsy, Digital Mammography, DBT and Phase I testing of 2D and 3D Phase Contrast Breast Imaging.
IAME requires everyone who is in a position to control the content of a CE/CME activity to disclose all relevant financial relationships with any commercial interest. This information is utilized to 1) determine if a conflict exists, 2) resolve the conflict by initiating a content validation process, and 3) advise learners of this information. Any individual who refuses to (or chooses not to) disclose relevant financial relationships will be disqualified from participating as an instructor, planner or manager and cannot have control of or responsibility for the development, management, presentation or evaluation of a CE/CME activity certified by IAME.
Laurie L. Fajardo, MD, MBA, FACR, FSBI, discloses she has had a consulting relationship with FUJIFILM Medical Systems U.S.A., Inc.
No individual at IAME who had control over the content of this program has relationships with FUJIFILM Medical Systems U.S.A., Inc. or any other commercial interest.
The Institute for Advanced Medical Education (IAME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Institute for Advanced Medical Education (IAME) designates this enduring material for a maximum of 1.5 AMA/PRA Category 1 CME Credits.™ Physicians should only claim credit commensurate with the extent of their participation in the activity.
Radiologic Technologists:(Pending Approval)-->
This course meets all criteria and has been approved by the AHRA, The Association for Medical Imaging Management for One and a half (1.5) ARRT Category A CE Credit.
Radiology Administrators:(Pending Approval)-->
This course meets all CRA renewal credit criteria and has been approved for One and a half (1.5) continuing education credit in the following CRA domains: Asset Resource Management (AM) and Operations Management (OM).
For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board or other credentialing organization.
To receive CME credits for participating in this CME activity you must successfully complete the online post examination with a passing score of 70% or higher.
To receive CE credits for participating in this CE activity you must successfully complete the online post examination with a passing score of 80% or higher.
Online examinations return an immediate grade report. Upon receiving a passing score click Continue and complete the evaluation form. To view and print your Statement of Credit click the Print/View Certificate button displayed from within your MyAR Archives page.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.